BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 20480504)

  • 1. Proteome profiling reveals gender differences in the composition of human serum.
    Miike K; Aoki M; Yamashita R; Takegawa Y; Saya H; Miike T; Yamamura K
    Proteomics; 2010 Jul; 10(14):2678-91. PubMed ID: 20480504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of alternative analytical techniques for the characterisation of the human serum proteome in HUPO Plasma Proteome Project.
    Li X; Gong Y; Wang Y; Wu S; Cai Y; He P; Lu Z; Ying W; Zhang Y; Jiao L; He H; Zhang Z; He F; Zhao X; Qian X
    Proteomics; 2005 Aug; 5(13):3423-41. PubMed ID: 16052619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidimensional proteomics of human serum using parallel chromatography of native constituents and microplate technology.
    Horn A; Kreusch S; Bublitz R; Hoppe H; Cumme GA; Schulze M; Moore T; Ditze G; Rhode H
    Proteomics; 2006 Jan; 6(2):559-70. PubMed ID: 16342237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel multidimensional protein identification technology approach combining protein size exclusion prefractionation, peptide zwitterion-ion hydrophilic interaction chromatography, and nano-ultraperformance RP chromatography/nESI-MS2 for the in-depth analysis of the serum proteome and phosphoproteome: application to clinical sera derived from humans with benign prostate hyperplasia.
    Garbis SD; Roumeliotis TI; Tyritzis SI; Zorpas KM; Pavlakis K; Constantinides CA
    Anal Chem; 2011 Feb; 83(3):708-18. PubMed ID: 21174401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unravelling in vitro variables of major importance for the outcome of mass spectrometry-based serum proteomics.
    West-Nørager M; Kelstrup CD; Schou C; Høgdall EV; Høgdall CK; Heegaard NH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):30-7. PubMed ID: 17112795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of electrophoretically derived protein mass estimates as additional constraints in proteome analysis of human serum based on MS/MS analysis.
    Kim JY; Lee JH; Park GW; Cho K; Kwon KH; Park YM; Cho SY; Paik YK; Yoo JS
    Proteomics; 2005 Aug; 5(13):3376-85. PubMed ID: 16052618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Derivatized cellulose combined with MALDI-TOF MS: a new tool for serum protein profiling.
    Feuerstein I; Rainer M; Bernardo K; Stecher G; Huck CW; Kofler K; Pelzer A; Horninger W; Klocker H; Bartsch G; Bonn GK
    J Proteome Res; 2005; 4(6):2320-6. PubMed ID: 16335981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of reproducibility of guanidination-dimethylation labeling and liquid chromatography matrix-assisted laser desorption ionization mass spectrometry for relative proteome quantification.
    Ji C; Zhang N; Damaraju S; Damaraju VL; Carpenter P; Cass CE; Li L
    Anal Chim Acta; 2007 Mar; 585(2):219-26. PubMed ID: 17386668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer.
    Ueda K; Katagiri T; Shimada T; Irie S; Sato TA; Nakamura Y; Daigo Y
    J Proteome Res; 2007 Sep; 6(9):3475-83. PubMed ID: 17705522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the SELDI ProteinChip human serum retentate by microcapillary liquid chromatography-tandem mass spectrometry.
    Zhou M; Prieto DA; Lucas DA; Chan KC; Issaq HJ; Veenstra TD; Conrads TP
    J Proteome Res; 2006 Sep; 5(9):2207-16. PubMed ID: 16944932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptidomic analysis of human blood specimens: comparison between plasma specimens and serum by differential peptide display.
    Tammen H; Schulte I; Hess R; Menzel C; Kellmann M; Mohring T; Schulz-Knappe P
    Proteomics; 2005 Aug; 5(13):3414-22. PubMed ID: 16038021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
    Yu KH; Rustgi AK; Blair IA
    J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A label-free nano-liquid chromatography-mass spectrometry approach for quantitative serum peptidomics in Crohn's disease patients.
    Nanni P; Levander F; Roda G; Caponi A; James P; Roda A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3127-36. PubMed ID: 19683480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of protein fragments as pattern features in MALDI-MS analyses of serum.
    Zimmerman LJ; Wernke GR; Caprioli RM; Liebler DC
    J Proteome Res; 2005; 4(5):1672-80. PubMed ID: 16212420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database.
    Omenn GS; States DJ; Adamski M; Blackwell TW; Menon R; Hermjakob H; Apweiler R; Haab BB; Simpson RJ; Eddes JS; Kapp EA; Moritz RL; Chan DW; Rai AJ; Admon A; Aebersold R; Eng J; Hancock WS; Hefta SA; Meyer H; Paik YK; Yoo JS; Ping P; Pounds J; Adkins J; Qian X; Wang R; Wasinger V; Wu CY; Zhao X; Zeng R; Archakov A; Tsugita A; Beer I; Pandey A; Pisano M; Andrews P; Tammen H; Speicher DW; Hanash SM
    Proteomics; 2005 Aug; 5(13):3226-45. PubMed ID: 16104056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproducibility of serum protein profiling by systematic assessment using solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry.
    Callesen AK; Christensen Rd; Madsen JS; Vach W; Zapico E; Cold S; Jørgensen PE; Mogensen O; Kruse TA; Jensen ON
    Rapid Commun Mass Spectrom; 2008; 22(3):291-300. PubMed ID: 18181248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isotope coded protein label quantification of serum proteins--comparison with the label-free LC-MS and validation using the MRM approach.
    Turtoi A; Mazzucchelli GD; De Pauw E
    Talanta; 2010 Feb; 80(4):1487-95. PubMed ID: 20082806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New pre-analytical approach for the deep proteome analysis of sera from pancreatitis and pancreas cancer patients.
    Fakelman F; Felix K; Büchler MW; Werner J
    Arch Physiol Biochem; 2010; 116(4-5):208-17. PubMed ID: 20815689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of affinity depletion of abundant proteins and reversed-phase fractionation in proteomic analysis of human plasma/serum.
    Zolotarjova N; Mrozinski P; Chen H; Martosella J
    J Chromatogr A; 2008 May; 1189(1-2):332-8. PubMed ID: 18154976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new analytical material-enhanced laser desorption ionization (MELDI) based approach for the determination of low-mass serum constituents using fullerene derivatives for selective enrichment.
    Vallant RM; Szabo Z; Trojer L; Najam-ul-Haq M; Rainer M; Huck CW; Bakry R; Bonn GK
    J Proteome Res; 2007 Jan; 6(1):44-53. PubMed ID: 17203947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.